---
edited: 2024-03-02
tags:
  - cardiology
---
### Stages

| Heart Failure Stage | Description                                                    | Treatment                                                                                                                                                               |
| ------------------- | -------------------------------------------------------------- | ----------------------------------------------------------------------------------------------------------------------------------------------------------------------- |
| **Asymptomatic**    |                                                                |                                                                                                                                                                         |
| Stage A             | Presence of [[Cardiovascular risk factors]]                    | [[Lifestyle modifications]]                                                                                                                                             |
| Stage B             | [[Pre-heart failure]]                                          | - [[Beta-Blockers]] + [[ACE-inhibitors]]/[[ARBs]]                                                                                                                       |
| **Symptomatic**     |                                                                |                                                                                                                                                                         |
| Stage C             | Signs/Symptoms present + Structural heart disease              | Give all of the following drugs:<br>- [[Beta-Blockers]] <br> - [[Diuretics]] <br> - [[RAAS inhibitors]] <br> - [[SGLT-2 Inhibitors]] <br> - [[Aldosterone antagonists]] |
| Stage D             | Symptoms disruptive to daily life ([[Advanced heart failure]]) | - [[Mechanical circulatory support]] <br>- [[Device therapy in heart failure]]<br> - IV [[Inotropic drugs]] <br> - [[Heart transplantation]] / Palliative care          |

### Additional drugs

| Class                                    | Indications                                                                      | Recommended Agents                                                                                      |
| ---------------------------------------- | -------------------------------------------------------------------------------- | ------------------------------------------------------------------------------------------------------- |
| Isosorbide dinitrate with hydralazine    | - Add to first-line therapy for African American patients with NYHA III–IV HFrEF | - Fixed-dose combination of isosorbide dinitrate/hydralazine OR - Isosorbide dinitrate PLUS hydralazine |
|                                          | - May be considered in patients who cannot tolerate ARNI, ACEIs, or ARBs         |                                                                                                         |
| If channel inhibitor                     | - Patients with NYHA II–III HFrEF and specific criteria                          | - [[Ivabradine]]                                                                                        |
| [[Digoxin]]                              | - Refractory symptoms despite first-line GDMT                                    | - Digoxin                                                                                               |
| [[Soluble guanylate cyclase stimulator]] | - Patients meeting specific criteria                                             | - Vericiguat                                                                                            |
| Omega-3 fatty acid                       | - May be added to first-line GDMT in patients with NYHA II–IV HFrEF              | - Omega-3 fatty acid (off-label)                                                                        |
### Drugs for preserved ejection fraction

| First-line Agents                               | Recommended Agents                      |
| ----------------------------------------------- | --------------------------------------- |
| [[SGLT-2 Inhibitors]] for all patients          | - Dapagliflozin                         |
|                                                 | - Empagliflozin                         |
| [[Loop diuretics]] for patients with congestion | - Furosemide                            |
|                                                 | - Torsemide                             |
| Other agents may be considered                  | - MRA, e.g., Spironolactone (off-label) |
|                                                 | - ARNI, i.e., Sacubitril/Valsartan      |
|                                                 | - ARB, e.g., Candesartan                |
